BEDFORD, Mass.--(BUSINESS WIRE)--Aug. 22, 2006--Cambridge Heart, Inc. (OTCBB:CAMH) today announced that an Executive Summary of the 2006 Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death has been jointly released by the American College of Cardiology (ACC), The American Heart Association (AHA) and the European Society of Cardiology (ESC). In this new guideline, collaborated on with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association, T-Wave Alternans received a Class IIa guideline under the section, Electrocardiographic Techniques and Measurements.
